Home » Cephalon Licenses Lupus Drug Candidate
Cephalon Licenses Lupus Drug Candidate
Cephalon Inc. said it is exercising an option to worldwide licensing rights to a lupus drug that is under development, triggering a $30 million fee to ImmuPharma PLC.
MSN Money
MSN Money
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May